Cargando…

A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis

Background: Cytokines have a major impact on the neurotransmitter networks that are involved in schizophrenia pathophysiology. First Episode Psychosis (FEP) patients exhibit abnormalities in cytokines levels prior to the start of treatment. Previous studies showed that antipsychotic treatment modula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcinowicz, Piotr, Więdłocha, Magdalena, Zborowska, Natalia, Dębowska, Weronika, Podwalski, Piotr, Misiak, Błażej, Tyburski, Ernest, Szulc, Agata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200072/ https://www.ncbi.nlm.nih.gov/pubmed/34199832 http://dx.doi.org/10.3390/jcm10112488

Ejemplares similares

Oxidative Stress Biomarkers among Schizophrenia Inpatients
por: Więdłocha, Magdalena, et al.
Publicado: (2023)

Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression
por: Dębowska, Weronika, et al.
Publicado: (2023)

Relationship of Corpus Callosum Integrity with Working Memory, Planning, and Speed of Processing in Patients with First-Episode and Chronic Schizophrenia
por: Tyburski, Ernest, et al.
Publicado: (2021)

Psychopathology and Stem Cell Mobilization in Ultra-High Risk of Psychosis and First-Episode Psychosis Patients
por: Waszczuk, Katarzyna, et al.
Publicado: (2022)

Relationship between White Matter Alterations and Pathophysiological Symptoms in Patients with Ultra-High Risk of Psychosis, First-Episode, and Chronic Schizophrenia
por: Waszczuk, Katarzyna, et al.
Publicado: (2022)

Effect of Antipsychotic Treatment on Neutrophil-to-Lymphocyte Ratio during Hospitalization for Acute Psychosis in the Course of Schizophrenia—A Cross-Sectional Retrospective Study
por: Dawidowski, Bartosz, et al.
Publicado: (2021)

Magnetic resonance diffusion tensor imaging in psychiatry: a narrative review of its potential role in diagnosis
por: Podwalski, Piotr, et al.
Publicado: (2020)

The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia
por: Rek-Owodziń, Katarzyna, et al.
Publicado: (2022)

The Role of Cytokines in the Pathogenesis of Schizophrenia
por: Dawidowski, Bartosz, et al.
Publicado: (2021)

Serum Inflammatory Markers and Their Associations with the Integrity of the Cingulum Bundle in Schizophrenia, from Prodromal Stages to Chronic Psychosis
por: Michalczyk, Anna, et al.
Publicado: (2022)

White Matter Integrity of the Corpus Callosum and Psychopathological Dimensions in Deficit and Non-Deficit Schizophrenia Patients
por: Podwalski, Piotr, et al.
Publicado: (2021)

Serum Inflammatory Markers and Integrity of the Superior Longitudinal Fasciculus and the Inferior Longitudinal Fasciculus in Schizophrenia, from Prodromal Stages to Chronic Psychosis—A Cross-Sectional Study
por: Michalczyk, Anna, et al.
Publicado: (2023)

Antipsychotic prescribing choices in patients with First Episode Psychosis
por: Fallon, J., et al.
Publicado: (2022)

Disturbances in White Matter Integrity in the Ultra-High-Risk Psychosis State—A Systematic Review
por: Waszczuk, Katarzyna, et al.
Publicado: (2021)

Cognitive Dysfunctions Measured with the MCCB in Deficit and Non-Deficit Schizophrenia
por: Plichta, Piotr, et al.
Publicado: (2023)

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients
por: Misiak, Błażej, et al.
Publicado: (2014)

Executive Functions and Psychopathology Dimensions in Deficit and Non-Deficit Schizophrenia
por: Bielecki, Maksymilian, et al.
Publicado: (2023)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes
por: Stevenson, J M, et al.
Publicado: (2016)

Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
por: Toll, Alba, et al.
Publicado: (2022)

The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics
por: Vassilopoulou, Emilia, et al.
Publicado: (2022)

Gradients of striatal function in antipsychotic-free first-episode psychosis and schizotypy
por: Oldehinkel, Marianne, et al.
Publicado: (2023)

Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis
por: Ottesen, Akiah, et al.
Publicado: (2023)

Psychopathology and Integrity of the Superior Longitudinal Fasciculus in Deficit and Nondeficit Schizophrenia
por: Podwalski, Piotr, et al.
Publicado: (2022)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
por: Kriisa, Kärt, et al.
Publicado: (2016)

Effectiveness of antipsychotics used in first-episode psychosis: a naturalistic cohort study
por: Whale, Richard, et al.
Publicado: (2016)

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis
por: Ansell, B. R. E., et al.
Publicado: (2015)

Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis
por: Ermakova, Anna O., et al.
Publicado: (2018)

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
por: Adam, Usman U, et al.
Publicado: (2014)

The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study
por: Bodnar, Michael, et al.
Publicado: (2016)

S19. THE ROLE OF ACE AS POSSIBLE BIOMARKER FOR TREATMENT RESISTANCE TO ANTIPSYCHOTICS IN FIRST EPISODE OF PSYCHOSIS
por: Luisa, Longo, et al.
Publicado: (2020)

Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study
por: Keating, Dolores, et al.
Publicado: (2021)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls
por: Dominicus, L. S., et al.
Publicado: (2023)

Serum and gene expression profile of cytokines in first-episode psychosis
por: Di Nicola, Marco, et al.
Publicado: (2013)

Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis
por: Briend, Frédéric, et al.
Publicado: (2020)

White Matter Integrity, Duration of Untreated Psychosis, and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2020)

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
por: Merritt, Kate, et al.
Publicado: (2019)

Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study
por: Merritt, Kate, et al.
Publicado: (2020)

Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis
por: Pollak, Thomas A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_34jrsji004k5ha0j8dlf6bo7jt